Investments in and Advances to Partially-Owned Affiliates	6 Months Ended
	Jun. 30, 2012
Investments in and Advances to Partially-Owned Affiliates [Abstract]
Investments in and Advances to Partially-Owned Affiliates	(5) Investments in and Advances to Partially-Owned Affiliates Investments in and advances to partially-owned affiliates consist primarily of the Company's equity stake in Zenara Pharma ("Zenara"). The Company recorded a loss of $368 and $853 for the three and six months ended June 30, 2012, respectively. These amounts include amortization expense of $238 and $494, for the three and six months ended June 30, 2012, respectively. The Company recorded a loss of $303 and $667 for the three and six months ended June 30, 2011, respectively. Those amounts include amortization expense of $288 and $570, for the three and six months ended June 30, 2011, respectively. Equity in losses of partially-owned affiliates also includes a loss of $15 and a gain of $262 for the three and six months ended June 30, 2012, respectively, related to an investment in a European joint venture. During the second quarter of 2012, the Company advanced $393 to Zenara.

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References+ Details